Home The Word Brain My Amedeo FAQ Privacy About Flying Publisher   


OLIENA
Language recovery after stroke
App | Video | PDF (278 pp) | Web

  Schizophrenia

  Free Subscription


Articles published in Psychiatry Res

Retrieve available abstracts of 359 articles:
HTML format
Text format



Single Articles


    November 2018
  1. FANG X, Chen Y, Wang Y, Zhang C, et al
    Identification of risk factors for suicidal ideation in patients with schizophrenia.
    Psychiatry Res. 2018;271:195-199.
    PubMed     Text format     Abstract available


  2. DAVIS PE, Webster LAD, Fernyhough C, Ralston K, et al
    Adult report of childhood imaginary companions and adversity relates to concurrent prodromal psychosis symptoms.
    Psychiatry Res. 2018;271:150-152.
    PubMed     Text format     Abstract available


  3. SKIBINSKA M, Kapelski P, Rajewska-Rager A, Szczepankiewicz A, et al
    Elevated brain-derived neurotrophic factor (BDNF) serum levels in an acute episode of schizophrenia in polish women: Correlation with clinical and metabolic parameters.
    Psychiatry Res. 2018;271:89-95.
    PubMed     Text format     Abstract available


  4. OZDIN S, Boke O
    Neutrophil/lymphocyte, platelet/lymphocyte and monocyte/lymphocyte ratios in different stages of schizophrenia.
    Psychiatry Res. 2018;271:131-135.
    PubMed     Text format     Abstract available


  5. WANG J, Zhang SM, Zhong SL, Mellsop G, et al
    Gender differences among homicide offenders with schizophrenia in Hunan Province, China.
    Psychiatry Res. 2018;271:124-130.
    PubMed     Text format     Abstract available


  6. VERAS AB, Chao MV, Getz M, Goetz R, et al
    Traumatic experiences and cognitive profiles of schizophrenia cases influenced by the BDNF Val66met polymorphism.
    Psychiatry Res. 2018;271:111-113.
    PubMed     Text format     Abstract available


  7. FRANKE ML, Lersner UV, Essel OQ, Adorjan K, et al
    The relationship between causal beliefs and desire for social distance towards people with schizophrenia and depression: Results from a survey of young Ghanaian adults.
    Psychiatry Res. 2018;271:220-225.
    PubMed     Text format     Abstract available


  8. PUGLIESE V, Bruni A, Carbone EA, Calabro G, et al
    Maternal stress, prenatal medical illnesses and obstetric complications: Risk factors for schizophrenia spectrum disorder, bipolar disorder and major depressive disorder.
    Psychiatry Res. 2018;271:23-30.
    PubMed     Text format     Abstract available


  9. KANG C, Zhou H, Yang J, Yang R, et al
    Course, outcome and diagnosis stability of early-onset schizophrenia in Yunnan Province, China-a three years follow-up study.
    Psychiatry Res. 2018;271:144-149.
    PubMed     Text format     Abstract available


  10. HOLM T, Thomsen DK, Bliksted V
    Themes of unfulfilled agency and communion in life stories of patients with schizophrenia.
    Psychiatry Res. 2018;269:772-778.
    PubMed     Text format     Abstract available


    October 2018
  11. IZON E, Berry K, Law H, French P, et al
    Expressed emotion (EE) in families of individuals at-risk of developing psychosis: A systematic review.
    Psychiatry Res. 2018;270:661-672.
    PubMed     Text format     Abstract available


  12. FAIOLA E, Meyhofer I, Steffens M, Kasparbauer AM, et al
    Combining trait and state model systems of psychosis: The effect of sleep deprivation on cognitive functions in schizotypal individuals.
    Psychiatry Res. 2018;270:639-648.
    PubMed     Text format     Abstract available


  13. KAIZERMAN-DINERMAN A, Roe D, Josman N
    An efficacy study of a metacognitive group intervention for people with schizophrenia.
    Psychiatry Res. 2018 Oct 13. pii: S0165-1781(17)32371.
    PubMed     Text format     Abstract available


  14. ROMERO-FERREIRO V, Aguado L, Torio I, Sanchez-Morla EM, et al
    Influence of emotional contexts on facial emotion attribution in schizophrenia.
    Psychiatry Res. 2018;270:554-559.
    PubMed     Text format     Abstract available


  15. KEINANEN J, Suvisaari J, Reinikainen J, Kieseppa T, et al
    Low-grade inflammation in first-episode psychosis is determined by increased waist circumference.
    Psychiatry Res. 2018;270:547-553.
    PubMed     Text format     Abstract available


  16. ADERY LH, Ichinose M, Torregrossa LJ, Wade J, et al
    The acceptability and feasibility of a novel virtual reality based social skills training game for schizophrenia: Preliminary findings.
    Psychiatry Res. 2018;270:496-502.
    PubMed     Text format     Abstract available


  17. OKUMURA Y, Sugiyama N, Noda T
    Timely follow-up visits after psychiatric hospitalization and readmission in schizophrenia and bipolar disorder in Japan.
    Psychiatry Res. 2018;270:490-495.
    PubMed     Text format     Abstract available


  18. CHEN S, Xia HS, Zhu F, Yin GZ, et al
    Association between decreased serum albumin levels and depressive symptoms in patients with schizophrenia in a Chinese Han population: A pilot study.
    Psychiatry Res. 2018;270:438-442.
    PubMed     Text format     Abstract available


  19. KRANE-GARTISER K, Henriksen TEG, Morken G, Vaaler AE, et al
    Motor activity patterns in acute schizophrenia and other psychotic disorders can be differentiated from bipolar mania and unipolar depression.
    Psychiatry Res. 2018;270:418-425.
    PubMed     Text format     Abstract available


  20. HASAN AA
    The correlation between the quality of life and clinical variables among outpatients with schizophrenia.
    Psychiatry Res. 2018;271:39-45.
    PubMed     Text format     Abstract available


  21. KASANOVA Z, Oorschot M, Myin-Germeys I
    Social anhedonia and asociality in psychosis revisited. An experience sampling study.
    Psychiatry Res. 2018;270:375-381.
    PubMed     Text format     Abstract available


    September 2018
  22. SACCHETTI E, Valsecchi P, Tamussi E, Paulli L, et al
    Psychomotor agitation in subjects hospitalized for an acute exacerbation of Schizophrenia.
    Psychiatry Res. 2018;270:357-364.
    PubMed     Text format     Abstract available


  23. GARCIA-CABEZA I, Diaz-Caneja CM, Ovejero M, de Portugal E, et al
    Adherence, insight and disability in paranoid schizophrenia.
    Psychiatry Res. 2018;270:274-280.
    PubMed     Text format     Abstract available


  24. MA JH, Sun XY, Guo TJ, Barot E, et al
    Association on DISC1 SNPs with schizophrenia risk: A meta-analysis.
    Psychiatry Res. 2018;270:306-309.
    PubMed     Text format     Abstract available


  25. GOMEZ-GASTIASORO A, Pena J, Zubiaurre-Elorza L, Ibarretxe-Bilbao N, et al
    Spanish adaptation and validation of the situational feature recognition test 2 (SFRT-2) in patients with schizophrenia and healthy controls.
    Psychiatry Res. 2018;270:225-231.
    PubMed     Text format     Abstract available


  26. KINCAID D, Shannon C, Boyd A, Hanna D, et al
    An investigation of associations between experience of childhood trauma and political violence and theory of mind impairments in schizophrenia.
    Psychiatry Res. 2018;270:293-297.
    PubMed     Text format     Abstract available


  27. KINSON RM, Hon C, Lee H, Abdin EB, et al
    Stigma and discrimination in individuals with first episode psychosis; one year after first contact with psychiatric services.
    Psychiatry Res. 2018;270:298-305.
    PubMed     Text format     Abstract available


  28. FEFEU M, De Maricourt P, Cachia A, Hoertel N, et al
    One-year mirror-image study of the impact of olanzapine long-acting injection on healthcare resource utilization and costs in severe schizophrenia.
    Psychiatry Res. 2018;270:205-210.
    PubMed     Text format     Abstract available


  29. KLEIN HS, Pinkham AE
    Examining reasoning biases in schizophrenia using a modified "Jumping to Conclusions" probabilistic reasoning task.
    Psychiatry Res. 2018;270:180-186.
    PubMed     Text format     Abstract available


  30. BERGSTROM T, Seikkula J, Alakare B, Maki P, et al
    The family-oriented open dialogue approach in the treatment of first-episode psychosis: Nineteen-year outcomes.
    Psychiatry Res. 2018;270:168-175.
    PubMed     Text format     Abstract available


  31. KO YS, Tsai HC, Chi MH, Su CC, et al
    Higher mortality and years of potential life lost of suicide in patients with schizophrenia.
    Psychiatry Res. 2018;270:531-537.
    PubMed     Text format     Abstract available


  32. LIU Y, Zhu H, Qian Z, Xu Y, et al
    Further evidence for the association between CMYA5 rs7714250 and schizophrenia in a Han Chinese population.
    Psychiatry Res. 2018 Sep 17. pii: S0165-1781(18)30747.
    PubMed     Text format    


  33. ALBERT U, Tomassi S, Maina G, Tosato S, et al
    Prevalence of non-psychotic disorders in ultra-high risk individuals and transition to psychosis: A systematic review.
    Psychiatry Res. 2018;270:1-12.
    PubMed     Text format     Abstract available


  34. FOND G, Godin O, Schurhoff F, Berna F, et al
    Hypovitaminosis D is associated with depression and anxiety in schizophrenia: Results from the national FACE-SZ cohort.
    Psychiatry Res. 2018;270:104-110.
    PubMed     Text format     Abstract available


  35. SMITH LM, Onwumere J, Craig T, Kuipers E, et al
    Caregiver correlates of patient-initiated violence in early psychosis.
    Psychiatry Res. 2018;270:412-417.
    PubMed     Text format     Abstract available


  36. KELLY DL, Li X, Kilday C, Feldman S, et al
    Increased circulating regulatory T cells in medicated people with schizophrenia.
    Psychiatry Res. 2018;269:517-523.
    PubMed     Text format     Abstract available


  37. DEPP CA, Villa J, Schembari BC, Harvey PD, et al
    Social cognition and short-term prediction of suicidal ideation in schizophrenia.
    Psychiatry Res. 2018;270:13-19.
    PubMed     Text format     Abstract available


  38. MILJEVIC CD, Nikolic-Kokic A, Blagojevic D, Milovanovic M, et al
    Association between neurological soft signs and antioxidant enzyme activity in schizophrenic patients.
    Psychiatry Res. 2018;269:746-752.
    PubMed     Text format     Abstract available


    August 2018
  39. IASEVOLI F, Avagliano C, Altavilla B, Barone A, et al
    Evaluation of a few discrete clinical markers may predict categorization of actively symptomatic non-acute schizophrenia patients as treatment resistant or responders: A study by ROC curve analysis and multivariate analyses.
    Psychiatry Res. 2018;269:481-493.
    PubMed     Text format     Abstract available


  40. MA J, Wang B, Gao X, Wu H, et al
    A comparative study of the typical toxic metals in serum by patients of schizophrenia and healthy controls in China.
    Psychiatry Res. 2018;269:558-564.
    PubMed     Text format     Abstract available


  41. SAUVE G, Malla A, Joober R, Brodeur MB, et al
    Comparing cognitive clusters across first- and multiple-episode of psychosis.
    Psychiatry Res. 2018;269:707-718.
    PubMed     Text format     Abstract available


  42. KOUIDRAT Y, Amad A, Stubbs B, Louhou R, et al
    Disordered eating behaviors as a potential obesogenic factor in schizophrenia.
    Psychiatry Res. 2018;269:450-454.
    PubMed     Text format     Abstract available


  43. CACCIOTTI-SAIJA C, Quintana DS, Alvares GA, Hickie IB, et al
    Reduced heart rate variability in a treatment-seeking early psychosis sample.
    Psychiatry Res. 2018;269:293-300.
    PubMed     Text format     Abstract available


  44. WANG X, Zhao J, Hu Y, Jiao Z, et al
    Sodium nitroprusside treatment for psychotic symptoms and cognitive deficits of schizophrenia: A randomized, double-blind, placebo-controlled trial.
    Psychiatry Res. 2018;269:271-277.
    PubMed     Text format     Abstract available


  45. WALSH-MESSINGER J, Wong PS, Antonius D, McMahon K, et al
    Sex differences in hedonic judgement of odors in schizophrenia cases and healthy controls.
    Psychiatry Res. 2018;269:345-353.
    PubMed     Text format     Abstract available


  46. MANSUETO G, Palmieri S, Faravelli C
    Parental style and Cloninger's model in psychosis.
    Psychiatry Res. 2018;269:221-228.
    PubMed     Text format     Abstract available


  47. FISH S, Toumaian M, Pappa E, Davies TJ, et al
    Modelling reaction time distribution of fast decision tasks in schizophrenia: Evidence for novel candidate endophenotypes.
    Psychiatry Res. 2018;269:212-220.
    PubMed     Text format     Abstract available


  48. AJNAKINA O, Trotta A, Forti MD, Stilo SA, et al
    Different types of childhood adversity and 5-year outcomes in a longitudinal cohort of first-episode psychosis patients.
    Psychiatry Res. 2018;269:199-206.
    PubMed     Text format     Abstract available


  49. LOPEZ-NAVARRO E
    Contributions of executive functions components to affective and cognitive theory of mind in outpatients diagnosed with schizophrenia.
    Psychiatry Res. 2018;269:124-125.
    PubMed     Text format     Abstract available


  50. GONZALEZ-BLANCO L, Maria P Garcia-Portilla, Garcia-Alvarez L, Lorena de la Fuente-Tomas, et al
    Elevated C-reactive protein as a predictor of a random one-year clinical course in the first ten years of schizophrenia.
    Psychiatry Res. 2018;269:688-691.
    PubMed     Text format     Abstract available


  51. LUO Y, Guo C, Zhang L, Pang L, et al
    County-level social factors and schizophrenia: A multilevel study of 1.9 million Chinese adults.
    Psychiatry Res. 2018;271:286-290.
    PubMed     Text format     Abstract available


  52. LANSER I, Browne J, Pinkham AE, Harvey PD, et al
    Evaluating social skill in individuals with schizophrenia with the brief impression questionnaire (BIQ).
    Psychiatry Res. 2018;269:38-44.
    PubMed     Text format     Abstract available


  53. PESTANA-SANTOS A, Loureiro L, Santos V, Carvalho I, et al
    Patients with schizophrenia assessing psychiatrists' communication skills.
    Psychiatry Res. 2018;269:13-20.
    PubMed     Text format     Abstract available


  54. DUDLEY R, Aynsworth C, Cheetham R, McCarthy-Jones S, et al
    Prevalence and characteristics of multi-modal hallucinations in people with psychosis who experience visual hallucinations.
    Psychiatry Res. 2018;269:25-30.
    PubMed     Text format     Abstract available


  55. DENG H, Verrico CD, Kosten TR, Nielsen DA, et al
    Psychosis and synthetic cannabinoids.
    Psychiatry Res. 2018;268:400-412.
    PubMed     Text format     Abstract available


  56. STRZELECKI D, Urban-Kowalczyk M, Wysokinski A
    Serum levels of TNF-alpha in patients with chronic schizophrenia during treatment augmentation with sarcosine (results of the PULSAR study).
    Psychiatry Res. 2018;268:447-453.
    PubMed     Text format     Abstract available


  57. LAGGER N, Amering M, Sibitz I, Gmeiner A, et al
    Stability and mutual prospective relationships of stereotyped beliefs about mental illness, hope and depressive symptoms among people with schizophrenia spectrum disorders.
    Psychiatry Res. 2018;268:484-489.
    PubMed     Text format     Abstract available


  58. COLIZZI M, Burnett N, Costa R, De Agostini M, et al
    Longitudinal assessment of the effect of cannabis use on hospital readmission rates in early psychosis: A 6-year follow-up in an inpatient cohort.
    Psychiatry Res. 2018;268:381-387.
    PubMed     Text format     Abstract available


  59. DRVARIC L, Bagby RM, Kiang M, Mizrahi R, et al
    Maladaptive personality traits in patients identified at lower-risk and higher-risk for psychosis.
    Psychiatry Res. 2018;268:348-353.
    PubMed     Text format     Abstract available


    July 2018
  60. DAHAN S, Bragazzi NL, Yogev A, Bar-Gad M, et al
    The relationship between serum cytokine levels and degree of psychosis in patients with schizophrenia.
    Psychiatry Res. 2018;268:467-472.
    PubMed     Text format     Abstract available


  61. BUONOCORE M, Bosia M, Baraldi MA, Bechi M, et al
    Exploring anxiety in schizophrenia: New light on a hidden figure.
    Psychiatry Res. 2018;268:312-316.
    PubMed     Text format     Abstract available


  62. ROY MA, Vallieres C, Lehoux C, Leclerc LD, et al
    More intensive probing increases the detection of social anxiety disorders in schizophrenia.
    Psychiatry Res. 2018;268:358-360.
    PubMed     Text format     Abstract available


  63. LALOYAUX J, Van der Linden M, Nuechterlein KH, Thonon B, et al
    A direct examination of the cognitive underpinnings of multitasking abilities: A first study examining schizophrenia.
    Psychiatry Res. 2018;268:288-296.
    PubMed     Text format     Abstract available


  64. CATHER C, Brunette MF, Mueser KT, Babbin SF, et al
    Impact of comprehensive treatment for first episode psychosis on substance use outcomes: A randomized controlled trial.
    Psychiatry Res. 2018;268:303-311.
    PubMed     Text format     Abstract available


  65. CHIU VW, Ree M, Janca A, Iyyalol R, et al
    Sleep profiles and CBT-I response in schizophrenia and related psychoses.
    Psychiatry Res. 2018;268:279-287.
    PubMed     Text format     Abstract available


  66. LU L, Zeng LN, Zong QQ, Rao WW, et al
    Quality of life in Chinese patients with schizophrenia: A meta-analysis.
    Psychiatry Res. 2018;268:392-399.
    PubMed     Text format     Abstract available


  67. CATALAN A, Angosto V, Diaz A, Martinez N, et al
    The relationship between theory of mind deficits and neurocognition in first episode-psychosis.
    Psychiatry Res. 2018;268:361-367.
    PubMed     Text format     Abstract available


  68. PAPP-HERTELENDI R, Tenyi T, Hadzsiev K, Hau L, et al
    First report on the association of SCN1A mutation, childhood schizophrenia and autism spectrum disorder without epilepsy.
    Psychiatry Res. 2018 Jul 19. pii: S0165-1781(18)30354.
    PubMed     Text format    


  69. KRISTOF Z, Kresznerits S, Olah M, Gyollai A, et al
    Mentalization and empathy as predictors of violence in schizophrenic patients: Comparison with nonviolent schizophrenic patients, violent controls and nonviolent controls.
    Psychiatry Res. 2018;268:198-205.
    PubMed     Text format     Abstract available


  70. SHAH P, Iwata Y, Plitman E, Brown EE, et al
    The impact of delay in clozapine initiation on treatment outcomes in patients with treatment-resistant schizophrenia: A systematic review.
    Psychiatry Res. 2018;268:114-122.
    PubMed     Text format     Abstract available


  71. ZHOU C, Chen J, Tang X, Feng X, et al
    DNA methylation and gene expression of the chemokine (C-X-C motif) ligand 1 in patients with deficit and non-deficit schizophrenia.
    Psychiatry Res. 2018;268:82-86.
    PubMed     Text format     Abstract available


  72. GORWOOD P, Mallet J, Lancrenon S
    Functional remission in schizophrenia: A FROGS-based definition and its convergent validity.
    Psychiatry Res. 2018;268:94-101.
    PubMed     Text format     Abstract available


    June 2018
  73. SANADA K, de Azua SR, Nakajima S, Alberich S, et al
    Correlates of neurocognitive functions in individuals at ultra-high risk for psychosis - A 6-month follow-up study.
    Psychiatry Res. 2018;268:1-7.
    PubMed     Text format     Abstract available


  74. KEANE BP, Peng Y, Demmin D, Silverstein SM, et al
    Intact perception of coherent motion, dynamic rigid form, and biological motion in chronic schizophrenia.
    Psychiatry Res. 2018;268:53-59.
    PubMed     Text format     Abstract available


  75. LEANZA L, Egloff L, Studerus E, Andreou C, et al
    The relationship between negative symptoms and cognitive functioning in patients at clinical high risk for psychosis.
    Psychiatry Res. 2018;268:21-27.
    PubMed     Text format     Abstract available


  76. LYSAKER PH, Irarrazaval L, Gagen EC, Armijo I, et al
    Metacognition in schizophrenia disorders: Comparisons with community controls and bipolar disorder: Replication with a Spanish language Chilean sample.
    Psychiatry Res. 2018;267:528-534.
    PubMed     Text format     Abstract available


  77. RAN MS, Xiao Y, Chui CHK, Hu XZ, et al
    Duration of untreated psychosis (DUP) and outcome of people with schizophrenia in rural China: 14-year follow-up study.
    Psychiatry Res. 2018;267:340-345.
    PubMed     Text format     Abstract available


  78. PURI P, Kumar D, Muralidharan K, Kishore MT, et al
    Individuals with Borderline Personality Disorder manifest cognitive biases implicated in psychosis.
    Psychiatry Res. 2018;267:414-419.
    PubMed     Text format     Abstract available


  79. LAMBDEN B, Berge J, Forsell Y
    Structured physical exercise and recovery from first episode psychosis in young adults, the FitForLife study.
    Psychiatry Res. 2018;267:346-353.
    PubMed     Text format     Abstract available


  80. DU X, Hong LE
    Test-retest reliability of short-interval intracortical inhibition and intracortical facilitation in patients with schizophrenia.
    Psychiatry Res. 2018;267:575-581.
    PubMed     Text format     Abstract available


  81. COSTA R, Bastos T, Probst M, Seabra A, et al
    Association of lifestyle-related factors and psychological factors on quality of life in people with schizophrenia.
    Psychiatry Res. 2018;267:382-393.
    PubMed     Text format     Abstract available


  82. FU S, Czajkowski N, Torgalsboen AK
    Cognitive improvement in first-episode schizophrenia and healthy controls: A 6-year multi-assessment follow-up study.
    Psychiatry Res. 2018;267:319-326.
    PubMed     Text format     Abstract available


  83. STEFANATOU P, Karatosidi CS, Tsompanaki E, Kattoulas E, et al
    Premorbid adjustment predictors of cognitive dysfunction in schizophrenia.
    Psychiatry Res. 2018;267:249-255.
    PubMed     Text format     Abstract available


  84. MARTENSEN LK, Hahn E, Cao TD, Schomerus G, et al
    Impact of perceived course of illness on the desire for social distance towards people with symptoms of schizophrenia in Hanoi, Vietnam.
    Psychiatry Res. 2018;268:206-210.
    PubMed     Text format     Abstract available


  85. KLAUNIG MJ, Trask CL, Neis AM, Cohn JR, et al
    Associations among domains of self-disturbance in schizophrenia.
    Psychiatry Res. 2018;267:187-194.
    PubMed     Text format     Abstract available


  86. BARRIOS M, Gomez-Benito J, Pino O, Rojo E, et al
    Functioning in patients with schizophrenia: A multicentre study evaluating the clinical perspective.
    Psychiatry Res. 2018 Jun 3. pii: S0165-1781(17)31379.
    PubMed     Text format     Abstract available


  87. MOHN C, Olsson AK, Helldin L
    Positive and negative affect in schizophrenia spectrum disorders: A forgotten dimension?
    Psychiatry Res. 2018;267:148-153.
    PubMed     Text format     Abstract available


    May 2018
  88. PAWELCZYK A, Lojek E, Zurner N, Gawlowska-Sawosz M, et al
    Higher-order language dysfunctions as a possible neurolinguistic endophenotype for schizophrenia: Evidence from patients and their unaffected first degree relatives.
    Psychiatry Res. 2018;267:63-72.
    PubMed     Text format     Abstract available


  89. FAERDEN A, Lyngstad SH, Simonsen C, Ringen PA, et al
    Reliability and validity of the self-report version of the apathy evaluation scale in first-episode Psychosis: Concordance with the clinical version at baseline and 12 months follow-up.
    Psychiatry Res. 2018;267:140-147.
    PubMed     Text format     Abstract available


  90. TAN CS, Lim LW, Ting DS
    Assessment of choroidal and retinal thickness in psychosis.
    Psychiatry Res. 2018 May 30. pii: S0165-1781(18)30704.
    PubMed     Text format    


  91. AHMAD M, Joe P, Malaspina D, Smith RT, et al
    Reply to comments on "A pilot study assessing retinal pathology in psychosis using optical coherence tomography: Choroidal and macular thickness".
    Psychiatry Res. 2018 May 30. pii: S0165-1781(18)30957.
    PubMed     Text format    


  92. HAMILTON JE, Heads AM, Meyer TD, Desai PV, et al
    Ethnic differences in the diagnosis of schizophrenia and mood disorders during admission to an academic safety-net psychiatric hospital.
    Psychiatry Res. 2018;267:160-167.
    PubMed     Text format     Abstract available


  93. HASEGAWA T, Hashimoto T, Kanahara N, Yamanaka H, et al
    Identifying improvable employment-related factors in schizophrenia patients.
    Psychiatry Res. 2018;266:199-205.
    PubMed     Text format     Abstract available


  94. CAQUEO-URIZAR A, Fond G, Urzua A, Boyer L, et al
    Gender differences in schizophrenia: A multicentric study from three Latin-America countries.
    Psychiatry Res. 2018;266:65-71.
    PubMed     Text format     Abstract available


  95. CHEN CK, Lee CY, Lee Y, Hung CF, et al
    Could schizoaffective disorder, schizophrenia and bipolar I disorder be distinguishable using cognitive profiles?
    Psychiatry Res. 2018;266:79-84.
    PubMed     Text format     Abstract available


  96. BRETT BL, McGovern JE, Choi J, Fiszdon JM, et al
    Improving treatment motivation in individuals with psychosis: Predictors of response to motivational enhancement.
    Psychiatry Res. 2018;266:36-39.
    PubMed     Text format     Abstract available


  97. CHUNG KH, Chen PH, Kuo CJ, Tsai SY, et al
    Risk factors for early circulatory mortality in patients with schizophrenia.
    Psychiatry Res. 2018;267:7-11.
    PubMed     Text format     Abstract available


  98. VASS E, Fekete Z, Simon V, Simon L, et al
    Interventions for the treatment of theory of mind deficits in schizophrenia: Systematic literature review.
    Psychiatry Res. 2018;267:37-47.
    PubMed     Text format     Abstract available


  99. SAVITZ A, Melkote R, Riley R, Pobre MA, et al
    Use of antipsychotic blood levels in clinician decision making: A cross-over study using clinical vignettes of patients with schizophrenia.
    Psychiatry Res. 2018;267:25-29.
    PubMed     Text format     Abstract available


  100. DE NIJS J, Meijer JH, de Haan L, Meijer CJ, et al
    Associations between olfactory identification and (social) cognitive functioning: A cross-sectional study in schizophrenia patients and healthy controls.
    Psychiatry Res. 2018;266:147-151.
    PubMed     Text format     Abstract available


  101. YANG Z, Li L, Li M
    De novo mutations as causes of schizophrenia.
    Psychiatry Res. 2018 May 18. pii: S0165-1781(18)30610.
    PubMed     Text format    


  102. JAGANNATH V, Gerstenberg M, Walitza S, Franscini M, et al
    Neuregulin 1 (NRG1) gene expression predicts functional outcomes in individuals at clinical high-risk for psychosis.
    Psychiatry Res. 2018;266:143-146.
    PubMed     Text format     Abstract available


  103. DE PAGE L, Mercenier S, Titeca P
    Assessing psychopathy in forensic schizophrenia spectrum disorders: Validating the Comprehensive Assessment of the Psychopathic Personality-Institutional Rating Scale (CAPP-IRS).
    Psychiatry Res. 2018;265:303-308.
    PubMed     Text format     Abstract available


  104. SIDDIQUI I, Remington G, Fervaha G, Fletcher PJ, et al
    Objective investigation of activity preference in schizophrenia: A pilot study.
    Psychiatry Res. 2018;267:551-559.
    PubMed     Text format     Abstract available


  105. HU TM, Ping LY, Hsu SH, Tsai HY, et al
    Mutation analysis of the WNT7A gene in patients with schizophrenia.
    Psychiatry Res. 2018;265:246-248.
    PubMed     Text format     Abstract available


  106. KANNO-NOZAKI K, Miura I, Kaneko H, Horikoshi S, et al
    Influences of the T102C polymorphism in the 5-HT2A receptor gene on the five-factor model of Positive and Negative Syndrome Scale and treatment response to aripiprazole in patients with acute schizophrenia.
    Psychiatry Res. 2018;265:244-245.
    PubMed     Text format    


  107. LABAD J, Armario A, Nadal R, Sole M, et al
    Clinical correlates of hypothalamic-pituitary-adrenal axis measures in individuals at risk for psychosis and with first-episode psychosis.
    Psychiatry Res. 2018;265:284-291.
    PubMed     Text format     Abstract available


  108. GROVE TB, Yao B, Mueller SA, McLaughlin M, et al
    A Bayesian model comparison approach to test the specificity of visual integration impairment in schizophrenia or psychosis.
    Psychiatry Res. 2018;265:271-278.
    PubMed     Text format     Abstract available


  109. CHOW TJ, Tee SF, Loh SY, Yong HS, et al
    Variants in ZNF804A and DTNBP1 assessed for cognitive impairment in schizophrenia using a multiplex family-based approach.
    Psychiatry Res. 2018 May 7. pii: S0165-1781(18)30118.
    PubMed     Text format    


  110. TAS C, Brown EC, Eskikurt G, Irmak S, et al
    Cortisol response to stress in schizophrenia: Associations with oxytocin, social support and social functioning.
    Psychiatry Res. 2018 May 7. pii: S0165-1781(17)31470.
    PubMed     Text format     Abstract available


  111. ZHU B, Chen C, Loftus EF, Dong Q, et al
    Intellectual factors in false memories of patients with schizophrenia.
    Psychiatry Res. 2018;265:256-262.
    PubMed     Text format     Abstract available


    April 2018
  112. DAS S, Punnoose VP, Doval N, Nair VY, et al
    Spirituality, religiousness and coping in patients with schizophrenia: A cross sectional study in a tertiary care hospital.
    Psychiatry Res. 2018;265:238-243.
    PubMed     Text format     Abstract available


  113. KURTZ MM, Gopal S, John S, Thara R, et al
    Cognition, social cognition and functional disability in early-stage schizophrenia: A study from southern India.
    Psychiatry Res. 2018;265:231-237.
    PubMed     Text format     Abstract available


  114. ZHOU W, Shi Y, Li F, Wu X, et al
    Study of the association between Schizophrenia and microduplication at the 16p11.2 locus in the Han Chinese population.
    Psychiatry Res. 2018;265:198-199.
    PubMed     Text format     Abstract available


  115. DE JONG S, van Donkersgoed R, Renard S, Carter S, et al
    Social-cognitive risk factors for violence in psychosis: A discriminant function analysis.
    Psychiatry Res. 2018;265:93-99.
    PubMed     Text format     Abstract available


  116. BONFILS KA, Minor KS, Leonhardt BL, Lysaker PH, et al
    Metacognitive self-reflectivity moderates the relationship between distress tolerance and empathy in schizophrenia.
    Psychiatry Res. 2018;265:1-6.
    PubMed     Text format     Abstract available


  117. MOHAMMADI A, Rashidi E, Amooeian VG
    Brain, blood, cerebrospinal fluid, and serum biomarkers in schizophrenia.
    Psychiatry Res. 2018;265:25-38.
    PubMed     Text format     Abstract available


  118. STRUGSTAD B, Lau B, Glenne Oie M
    Associations between cognition and internalizing problems in young adults with early-onset schizophrenia: A 13-year follow-up study.
    Psychiatry Res. 2018;265:161-166.
    PubMed     Text format     Abstract available


  119. YE F, Zhan Q, Xiao W, Tang X, et al
    Altered serum levels of vascular endothelial growth factor in first-episode drug-naive and chronic medicated schizophrenia.
    Psychiatry Res. 2018;264:361-365.
    PubMed     Text format     Abstract available


  120. HARO JM, Altamura C, Corral R, Elkis H, et al
    Understanding the course of persistent symptoms in schizophrenia: Longitudinal findings from the pattern study.
    Psychiatry Res. 2018;267:56-62.
    PubMed     Text format     Abstract available


  121. ZHAO S, Xia H, Mu J, Wang L, et al
    10-year CVD risk in Han Chinese mainland patients with schizophrenia.
    Psychiatry Res. 2018;264:322-326.
    PubMed     Text format     Abstract available


  122. MA J, Shang S, Wang J, Zhang T, et al
    Identification of miR-22-3p, miR-92a-3p, and miR-137 in peripheral blood as biomarker for schizophrenia.
    Psychiatry Res. 2018;265:70-76.
    PubMed     Text format     Abstract available


  123. ANDERSEN EH, Lewis GF, Belger A
    Aberrant parasympathetic reactivity to acute psychosocial stress in male patients with schizophrenia spectrum disorders.
    Psychiatry Res. 2018;265:39-47.
    PubMed     Text format     Abstract available


  124. XU YM, Li F, Liu XB, Zhong BL, et al
    Depressive symptoms in Chinese male inpatients with schizophrenia: Prevalence and clinical correlates.
    Psychiatry Res. 2018;264:380-384.
    PubMed     Text format     Abstract available


  125. VOCE A, McKetin R, Burns R, Castle D, et al
    The relationship between illicit amphetamine use and psychiatric symptom profiles in schizophrenia and affective psychoses.
    Psychiatry Res. 2018;265:19-24.
    PubMed     Text format     Abstract available


  126. HICKLING LM, Kouvaras S, Nterian Z, Perez-Iglesias R, et al
    Non-adherence to antipsychotic medication in first-episode psychosis patients.
    Psychiatry Res. 2018;264:151-154.
    PubMed     Text format     Abstract available


  127. LOPEZ-NAVARRO E, Del Canto C, Mayol A, Fernandez-Alonso O, et al
    Psychotic symptoms and quality of life: A mediation analysis of daily-life coping.
    Psychiatry Res. 2018;262:505-509.
    PubMed     Text format     Abstract available


    March 2018
  128. KANG M, Bang M, Lee SY, Lee E, et al
    Coping styles in individuals at ultra-high risk for psychosis: Associations with cognitive appraisals.
    Psychiatry Res. 2018;264:162-168.
    PubMed     Text format     Abstract available


  129. GUO W, Zhang F, Liu F, Chen J, et al
    Cerebellar abnormalities in first-episode, drug-naive schizophrenia at rest.
    Psychiatry Res. 2018 Mar 29. pii: S0925-4927(17)30308.
    PubMed     Text format     Abstract available


  130. MATSUMOTO J, Nagaoka A, Kunii Y, Miura I, et al
    Effects of the -141C insertion/deletion polymorphism in the dopamine D2 receptor gene on the dopamine system in the striatum in patients with schizophrenia.
    Psychiatry Res. 2018;264:116-118.
    PubMed     Text format     Abstract available


  131. ABUSH H, Ghose S, Van Enkevort EA, Clementz BA, et al
    Associations between adolescent cannabis use and brain structure in psychosis.
    Psychiatry Res. 2018 Mar 28. pii: S0925-4927(17)30314.
    PubMed     Text format     Abstract available


  132. THONSE U, Behere RV, Praharaj SK, Sharma PSVN, et al
    Facial emotion recognition, socio-occupational functioning and expressed emotions in schizophrenia versus bipolar disorder.
    Psychiatry Res. 2018;264:354-360.
    PubMed     Text format     Abstract available


  133. AYDIN O, Lysaker PH, Balikci K, Unal-Aydin P, et al
    Associations of oxytocin and vasopressin plasma levels with neurocognitive, social cognitive and meta cognitive function in schizophrenia.
    Psychiatry Res. 2018 Mar 23. pii: S0165-1781(17)31776.
    PubMed     Text format     Abstract available


  134. LIN CH, Lin SC, Huang YH, Wang FC, et al
    Early prediction of olanzapine-induced weight gain for schizophrenia patients.
    Psychiatry Res. 2018;263:207-211.
    PubMed     Text format     Abstract available


  135. KIM DD, Barr AM, Thornton AE, Honer WG, et al
    Statin add-on therapy for schizophrenia: Is the effect the same for clozapine?
    Psychiatry Res. 2018 Mar 22. pii: S0165-1781(18)30090.
    PubMed     Text format    


  136. VAZQUEZ MOREJON AJ, Vazquez-Morejon R, Bellido Zanin G
    Behavior Problems Inventory (BPI): Psychometric characteristics of an instrument for routine assessment of persons with psychoses and related disorders.
    Psychiatry Res. 2018 Mar 22. pii: S0165-1781(17)31662.
    PubMed     Text format     Abstract available


  137. KOTHER U, Lincoln TM, Moritz S
    Emotion perception and overconfidence in errors under stress in psychosis.
    Psychiatry Res. 2018 Mar 21. pii: S0165-1781(17)31081.
    PubMed     Text format     Abstract available


  138. WARD HB, Szabo ST, Rakesh G
    Maintenance ECT in schizophrenia: A systematic review.
    Psychiatry Res. 2018;264:131-142.
    PubMed     Text format     Abstract available


  139. DEGNAN A, Berry K, James S, Edge D, et al
    Development, validation and cultural-adaptation of the knowledge about psychosis questionnaire for African-Caribbean people in the UK.
    Psychiatry Res. 2018;263:199-206.
    PubMed     Text format     Abstract available


  140. LINDGREN M, Torniainen-Holm M, Heiskanen I, Voutilainen G, et al
    Theory of mind in a first-episode psychosis population using the Hinting Task.
    Psychiatry Res. 2018;263:185-192.
    PubMed     Text format     Abstract available


  141. XIU MH, Wang D, Chen S, Du XD, et al
    Interleukin-3, symptoms and cognitive deficits in first-episode drug-naive and chronic medicated schizophrenia.
    Psychiatry Res. 2018;263:147-153.
    PubMed     Text format     Abstract available


  142. DE MOURA AM, Pinaya WHL, Gadelha A, Zugman A, et al
    Investigating brain structural patterns in first episode psychosis and schizophrenia using MRI and a machine learning approach.
    Psychiatry Res. 2018 Mar 6. pii: S0925-4927(17)30133.
    PubMed     Text format     Abstract available


  143. THOMAS EC, Murakami-Brundage J, Bertolami N, Beck AT, et al
    Beck Self-Esteem Scale-Short Form: Development and psychometric evaluation of a scale for the assessment of self-concept in schizophrenia.
    Psychiatry Res. 2018;263:173-180.
    PubMed     Text format     Abstract available


  144. JOE P, Ahmad M, Riley G, Weissman J, et al
    A pilot study assessing retinal pathology in psychosis using optical coherence tomography: Choroidal and macular thickness.
    Psychiatry Res. 2018;263:158-161.
    PubMed     Text format     Abstract available


  145. KRUKOW P, Jonak K, Karakula-Juchnowicz H, Podkowinski A, et al
    Disturbed functional connectivity within the left prefrontal cortex and sensorimotor areas predicts impaired cognitive speed in patients with first-episode schizophrenia.
    Psychiatry Res. 2018 Mar 4. pii: S0925-4927(18)30018.
    PubMed     Text format     Abstract available


    February 2018
  146. AIKAWA S, Kobayashi H, Nemoto T, Matsuo S, et al
    Social anxiety and risk factors in patients with schizophrenia: Relationship with duration of untreated psychosis.
    Psychiatry Res. 2018;263:94-100.
    PubMed     Text format     Abstract available


  147. BRIEND F, Nathou C, Kauffmann F, Delcroix N, et al
    Theta burst stimulation on social cognition and N-Acetyl aspartate in two patients with schizophrenia.
    Psychiatry Res. 2018 Feb 18. pii: S0925-4927(17)30344.
    PubMed     Text format    


  148. HANSBAUER M, Wobrock T, Kunze B, Langguth B, et al
    Efficacy of high-frequency repetitive transcranial magnetic stimulation on PANSS factors in schizophrenia with predominant negative symptoms - Results from an exploratory re-analysis.
    Psychiatry Res. 2018;263:22-29.
    PubMed     Text format     Abstract available


  149. PAUSELLI L, Halpern B, Cleary SD, Ku B, et al
    Computational linguistic analysis applied to a semantic fluency task to measure derailment and tangentiality in schizophrenia.
    Psychiatry Res. 2018;263:74-79.
    PubMed     Text format     Abstract available


  150. MAN L, Lv X, Du XD, Yin G, et al
    Cognitive impairments and low BDNF serum levels in first-episode drug-naive patients with schizophrenia.
    Psychiatry Res. 2018;263:1-6.
    PubMed     Text format     Abstract available


  151. SUM MY, Tay KH, Sengupta S, Sim K, et al
    Neurocognitive functioning and quality of life in patients with and without deficit syndrome of schizophrenia.
    Psychiatry Res. 2018;263:54-60.
    PubMed     Text format     Abstract available


  152. BUSTAN Y, Drapisz A, Ben Dor DH, Avrahami M, et al
    Elevated neutrophil to lymphocyte ratio in non-affective psychotic adolescent inpatients: Evidence for early association between inflammation and psychosis.
    Psychiatry Res. 2018;262:149-153.
    PubMed     Text format     Abstract available


  153. CANTISANI A, Stegmayer K, Federspiel A, Bohlhalter S, et al
    Blood perfusion in left inferior and middle frontal gyrus predicts communication skills in schizophrenia.
    Psychiatry Res. 2018 Feb 10. pii: S0925-4927(17)30229.
    PubMed     Text format     Abstract available


  154. CLELLAND JD, Read LL, Smeed J, Clelland CL, et al
    Regulation of cortical and peripheral GCH1 expression and biopterin levels in schizophrenia-spectrum disorders.
    Psychiatry Res. 2018;262:229-236.
    PubMed     Text format     Abstract available


  155. MCGREGOR N, Thompson N, O'Connell KS, Emsley R, et al
    Modification of the association between antipsychotic treatment response and childhood adversity by MMP9 gene variants in a first-episode schizophrenia cohort.
    Psychiatry Res. 2018;262:141-148.
    PubMed     Text format     Abstract available


  156. ZHANG T, Xu L, Cui H, Tang Y, et al
    Changes in correlation characteristics of time consumption and mind-reading performance in pre-onset and post-onset psychosis.
    Psychiatry Res. 2018;262:168-174.
    PubMed     Text format     Abstract available


  157. JOHANNESEN JK, Fiszdon JM, Weinstein A, Ciosek D, et al
    The Social Attribution Task - Multiple Choice (SAT-MC): Psychometric comparison with social cognitive measures for schizophrenia research.
    Psychiatry Res. 2018;262:154-161.
    PubMed     Text format     Abstract available


  158. SHEN H, Li R, Yan R, Zhou X, et al
    Adjunctive therapy with statins in schizophrenia patients: A meta-analysis and implications.
    Psychiatry Res. 2018;262:84-93.
    PubMed     Text format     Abstract available


  159. GHAJAR A, Khoaie-Ardakani MR, Shahmoradi Z, Alavi AR, et al
    L-carnosine as an add-on to risperidone for treatment of negative symptoms in patients with stable schizophrenia: A double-blind, randomized placebo-controlled trial.
    Psychiatry Res. 2018;262:94-101.
    PubMed     Text format     Abstract available


  160. LEE SC, Tang SF, Lu WS, Huang SL, et al
    Corrigendum to "Minimal detectable change of the Personal and Social Performance scale in individuals with schizophrenia" [Psychiatry Research 246 (2016) 725-729].
    Psychiatry Res. 2018;260:508.
    PubMed     Text format    


  161. MARGULSKA A, Kozlowska E, Wysokinski A
    Effect of clozapine dose and concentration on fasting concentration of appetite regulating peptides.
    Psychiatry Res. 2018;260:473-477.
    PubMed     Text format     Abstract available


  162. VANCAMPFORT D, Probst M, Basangwa D, De Hert M, et al
    Adherence to physical activity recommendations and physical and mental health risk in people with severe mental illness in Uganda.
    Psychiatry Res. 2018;260:236-240.
    PubMed     Text format     Abstract available


  163. OLUWOYE O, Hirchak K, Leickly E, Skalisky J, et al
    Interaction between pre-treatment drug use and heterogeneity of psychiatric diagnosis predicts outcomes in outpatients with co-occurring disorders.
    Psychiatry Res. 2018;260:233-235.
    PubMed     Text format     Abstract available


  164. SIMON JJ, Zimmermann J, Cordeiro SA, Maree I, et al
    Psychometric evaluation of the Temporal Experience of Pleasure Scale (TEPS) in a German sample.
    Psychiatry Res. 2018;260:138-143.
    PubMed     Text format     Abstract available


    January 2018
  165. PLITMAN E, Chavez S, Nakajima S, Iwata Y, et al
    Striatal neurometabolite levels in patients with schizophrenia undergoing long-term antipsychotic treatment: A proton magnetic resonance spectroscopy and reliability study.
    Psychiatry Res. 2018;273:16-24.
    PubMed     Text format     Abstract available


  166. LI X, Tian Q, Bo Q, Zhang G, et al
    Impact of childhood trauma on sensorimotor gating in Chinese patients with chronic schizophrenia.
    Psychiatry Res. 2018;263:69-73.
    PubMed     Text format     Abstract available


  167. ZHANG X, Gao J, Zhu F, Wang W, et al
    Reduced white matter connectivity associated with auditory verbal hallucinations in first-episode and chronic schizophrenia: A diffusion tensor imaging study.
    Psychiatry Res. 2018 Jan 25. pii: S0925-4927(17)30315.
    PubMed     Text format     Abstract available


  168. KIM DD, Lang DJ, Procyshyn RM, Woodward ML, et al
    Reduced cardiovascular fitness associated with exposure to clozapine in individuals with chronic schizophrenia.
    Psychiatry Res. 2018;262:28-33.
    PubMed     Text format     Abstract available


  169. SEVILLA-LLEWELLYN-JONES J, Camino G, Russo DA, Painter M, et al
    Clinically significant personality traits in individuals at high risk of developing psychosis.
    Psychiatry Res. 2018;261:498-503.
    PubMed     Text format     Abstract available


  170. MORKVED N, Winje D, Dovran A, Arefjord K, et al
    Childhood trauma in schizophrenia spectrum disorders as compared to substance abuse disorders.
    Psychiatry Res. 2018;261:481-487.
    PubMed     Text format     Abstract available


  171. FELDHAUS T, Falke S, von Gruchalla L, Maisch B, et al
    The impact of self-stigmatization on medication attitude in schizophrenia patients.
    Psychiatry Res. 2018;261:391-399.
    PubMed     Text format     Abstract available


  172. HO KKY, Lui SSY, Wang Y, Yeung HKH, et al
    Theory of mind performances in first-episode schizophrenia patients: An 18-month follow-up study.
    Psychiatry Res. 2018;261:357-360.
    PubMed     Text format     Abstract available


  173. SOYATA AZ, Akisik S, Inhanli D, Noyan H, et al
    Relationship of obsessive-compulsive symptoms to clinical variables and cognitive functions in individuals at ultra high risk for psychosis.
    Psychiatry Res. 2018;261:332-337.
    PubMed     Text format     Abstract available


  174. SURI G, Lavaysse LM, Young G, Moodie C, et al
    An investigation into the drivers of avolition in schizophrenia.
    Psychiatry Res. 2018;261:225-231.
    PubMed     Text format     Abstract available


  175. DENG H, Mohite S, Suchting R, Nielsen DA, et al
    Impact of synthetic cannabinoid use on hospital stay in patients with bipolar disorder versus schizophrenia, or other psychotic disorders.
    Psychiatry Res. 2018;261:248-252.
    PubMed     Text format     Abstract available


  176. KOIKE S, Yamaguchi S, Ojio Y, Ando S, et al
    Social distance toward people with schizophrenia is associated with favorable understanding and negative stereotype.
    Psychiatry Res. 2018;261:264-268.
    PubMed     Text format     Abstract available


  177. MARGGRAF MP, Cohen AS, Davis BJ, DeCrescenzo P, et al
    Semantic coherence in psychometric schizotypy: An investigation using Latent Semantic Analysis.
    Psychiatry Res. 2018;259:63-67.
    PubMed     Text format     Abstract available


    December 2017
  178. NIMGAONKAR VL, Dickerson F, Pouget JG, Chowdari K, et al
    Joint evaluation of serum C-Reactive Protein levels and polygenic risk scores as risk factors for schizophrenia.
    Psychiatry Res. 2017;261:148-153.
    PubMed     Text format     Abstract available


  179. WANG L, Jin S, He K, Chen X, et al
    Increased delayed reward during intertemporal decision-making in schizophrenic patients and their unaffected siblings.
    Psychiatry Res. 2017;262:246-253.
    PubMed     Text format     Abstract available


  180. UNAL K, Yuksel RN, Turhan T, Sezer S, et al
    The association of serum nesfatin-1 and ghrelin levels with metabolic syndrome in patients with schizophrenia.
    Psychiatry Res. 2017;261:45-49.
    PubMed     Text format     Abstract available


  181. MEZQUIDA G, Cabrera B, Martinez-Aran A, Vieta E, et al
    Detection of early psychotic symptoms: Validation of the Spanish version of the "Symptom Onset in Schizophrenia (SOS) inventory".
    Psychiatry Res. 2017;261:68-72.
    PubMed     Text format     Abstract available


  182. WON GH, Kim JW, Choi TY, Lee YS, et al
    Theta-phase gamma-amplitude coupling as a neurophysiological marker in neuroleptic-naive schizophrenia.
    Psychiatry Res. 2017;260:406-411.
    PubMed     Text format     Abstract available


  183. WOOD L, Byrne R, Enache G, Morrison AP, et al
    A brief cognitive therapy intervention for internalised stigma in acute inpatients who experience psychosis: A feasibility randomised controlled trial.
    Psychiatry Res. 2017;262:303-310.
    PubMed     Text format     Abstract available


  184. BEHDANI F, Roudbaraki SN, Saberi-Karimian M, Tayefi M, et al
    Assessment of the efficacy of omega-3 fatty acids on metabolic and inflammatory parameters in patients with schizophrenia taking clozapine and sodium valproate.
    Psychiatry Res. 2017;261:243-247.
    PubMed     Text format     Abstract available


  185. VAN NIEROP M, Lecei A, Myin-Germeys I, Collip D, et al
    Stress reactivity links childhood trauma exposure to an admixture of depressive, anxiety, and psychosis symptoms.
    Psychiatry Res. 2017;260:451-457.
    PubMed     Text format     Abstract available


  186. PENNER J, Osuch EA, Schaefer B, Theberge J, et al
    Higher order thalamic nuclei resting network connectivity in early schizophrenia and major depressive disorder.
    Psychiatry Res. 2017;272:7-16.
    PubMed     Text format     Abstract available


  187. MOODY G, Miller BJ
    Total and differential white blood cell counts and hemodynamic parameters in first-episode psychosis.
    Psychiatry Res. 2017;260:307-312.
    PubMed     Text format     Abstract available


  188. LEENDERTSE P, Myin-Germeys I, Lataster T, Simons CJP, et al
    Subjective quality of life in psychosis: Evidence for an association with real world functioning?
    Psychiatry Res. 2017;261:116-123.
    PubMed     Text format     Abstract available


  189. OLIVEIRA IAF, Guimaraes TM, Souza RM, Dos Santos AC, et al
    Brain functional and perfusional alterations in schizophrenia: an arterial spin labeling study.
    Psychiatry Res. 2017 Dec 5. pii: S0925-4927(17)30214.
    PubMed     Text format     Abstract available


  190. MOHN C, Torgalsboen AK
    Details of attention and learning change in first-episode schizophrenia.
    Psychiatry Res. 2017;260:324-330.
    PubMed     Text format     Abstract available


  191. LIN YC, Lai CL, Chan HY
    The association between rehabilitation programs and metabolic syndrome in chronic inpatients with schizophrenia.
    Psychiatry Res. 2017;260:227-232.
    PubMed     Text format     Abstract available


    November 2017
  192. ZHOU SS, Zhou Y
    Is the association between season of birth and schizophrenia due to neonatal cold exposure-induced permanent defects in skin functions?
    Psychiatry Res. 2017 Nov 28. pii: S0165-1781(17)30390.
    PubMed     Text format    


  193. TANG SF, Chen IH, Chiang HY, Wu CT, et al
    A comparison between the original and Tablet-based Symbol Digit Modalities Test in patients with schizophrenia: Test-retest agreement, random measurement error, practice effect, and ecological validity.
    Psychiatry Res. 2017;260:199-206.
    PubMed     Text format     Abstract available


  194. CHIU EC, Hung TM, Huang CM, Lee SC, et al
    Responsiveness of the Personal and Social Performance scale in patients with schizophrenia.
    Psychiatry Res. 2017;260:338-342.
    PubMed     Text format     Abstract available


  195. PAROLA A, Berardinelli L, Bosco FM
    Cognitive abilities and theory of mind in explaining communicative-pragmatic disorders in patients with schizophrenia.
    Psychiatry Res. 2017;260:144-151.
    PubMed     Text format     Abstract available


  196. SHARMA A, Kumar A, Singh S, Bhatia T, et al
    Altered resting state functional connectivity in early course schizophrenia.
    Psychiatry Res. 2017;271:17-23.
    PubMed     Text format     Abstract available


  197. DOMANY Y, Levy A, Cassan SM, Tarrasch R, et al
    Clinical utility of biomarkers of the hand in the diagnosis of schizophrenia.
    Psychiatry Res. 2017;260:105-110.
    PubMed     Text format     Abstract available


  198. ALLOTT KA, Yuen HP, Bartholomeusz CF, Rapado-Castro M, et al
    Stress hormones and verbal memory in young people over the first 12 weeks of treatment for psychosis.
    Psychiatry Res. 2017;260:60-66.
    PubMed     Text format     Abstract available


  199. VINGERHOETS C, Bloemen OJN, Boot E, Bakker G, et al
    Dopamine in high-risk populations: A comparison of subjects with 22q11.2 deletion syndrome and subjects at ultra high-risk for psychosis.
    Psychiatry Res. 2017 Nov 21. pii: S0925-4927(17)30192.
    PubMed     Text format     Abstract available


  200. CROCA M, Lagodka A, Gadel R, Bourdel MC, et al
    Theory of mind and schizophrenia in young and middle-aged patients: Influence of executive functions.
    Psychiatry Res. 2017;259:532-537.
    PubMed     Text format     Abstract available


  201. GUR S, Weizman S, Stubbs B, Matalon A, et al
    Mortality, morbidity and medical resources utilization of patients with schizophrenia: A case-control community-based study.
    Psychiatry Res. 2017;260:177-181.
    PubMed     Text format     Abstract available


  202. SUN Q, Huang X, Niu W, Yu T, et al
    The promoter polymorphisms in HTR2A gene associated with schizophrenia in Chinese of Han ethnicity.
    Psychiatry Res. 2017 Nov 15. pii: S0165-1781(17)30794.
    PubMed     Text format    


  203. RUZIBIZA C, Grattan RE, Eder R, Linscott RJ, et al
    Components of schizophrenia liability are not uniformly associated with stress sensitivity, resilience, and coping.
    Psychiatry Res. 2017;260:10-16.
    PubMed     Text format     Abstract available


  204. NOMURA I, Kishi T, Ikuta T, Iwata N, et al
    Statin add-on therapy in the antipsychotic treatment of schizophrenia: A meta-analysis.
    Psychiatry Res. 2017;260:41-47.
    PubMed     Text format     Abstract available


  205. PERLINI C, Bellani M, Finos L, Lasalvia A, et al
    Non literal language comprehension in a large sample of first episode psychosis patients in adulthood.
    Psychiatry Res. 2017;260:78-89.
    PubMed     Text format     Abstract available


  206. DAS S, Sengupta S, Pathak K, Sah D, et al
    Aggression as an independent entity even in psychosis - The role of cortisol.
    Psychiatry Res. 2017;259:405-411.
    PubMed     Text format     Abstract available


  207. VAN DIJK FA, Schirmbeck F, Haan L
    A longitudinal analysis of the effects of neuroticism and extraversion on subjective well-being in patients with schizophrenia.
    Psychiatry Res. 2017;259:538-544.
    PubMed     Text format     Abstract available


  208. CAO B, Sun XY, Zhang CB, Yan JJ, et al
    Association between B vitamins and schizophrenia: A population-based case-control study.
    Psychiatry Res. 2017;259:501-505.
    PubMed     Text format     Abstract available


  209. AHMED AO, Richardson J, Buckner A, Romanoff S, et al
    Do cognitive deficits predict negative emotionality and aggression in schizophrenia?
    Psychiatry Res. 2017;259:350-357.
    PubMed     Text format     Abstract available


  210. UNGPRASERT P, Wijarnpreecha K, Cheungpasitporn W
    Patients with schizophrenia have a higher risk of psoriasis: A systematic review and meta-analysis.
    Psychiatry Res. 2017;259:422-426.
    PubMed     Text format     Abstract available


  211. LANGEVELD J, Bjorkly S, Evensen J, Joa I, et al
    A 10-year follow-up study of violent victimization in first episode psychosis: Risk and protective factors.
    Psychiatry Res. 2017;259:545-549.
    PubMed     Text format     Abstract available


  212. DE LEON PP, Gerretsen P, Shah P, Saracco-Alvarez R, et al
    Cross-cultural psychometric assessment of the VAGUS insight into psychosis scale - Spanish version.
    Psychiatry Res. 2017;259:450-454.
    PubMed     Text format     Abstract available


    October 2017
  213. GSPANDL S, Peirson RP, Nahhas RW, Skale TG, et al
    Comparing Global Assessment of Functioning (GAF) and World Health Organization Disability Assessment Schedule (WHODAS) 2.0 in schizophrenia.
    Psychiatry Res. 2017;259:251-253.
    PubMed     Text format     Abstract available


  214. LUBEIRO A, de Luis-Garcia R, Rodriguez M, Alvarez A, et al
    Biological and cognitive correlates of cortical curvature in schizophrenia.
    Psychiatry Res. 2017;270:68-75.
    PubMed     Text format     Abstract available


  215. GUIMOND S, Beland S, Lepage M
    Strategy for Semantic Association Memory (SESAME) training: Effects on brain functioning in schizophrenia.
    Psychiatry Res. 2017 Oct 25. pii: S0925-4927(17)30167.
    PubMed     Text format     Abstract available


  216. KRETCHY IA, Osafo J, Agyemang SA, Appiah B, et al
    Psychological burden and caregiver-reported non-adherence to psychotropic medications among patients with schizophrenia.
    Psychiatry Res. 2017;259:289-294.
    PubMed     Text format     Abstract available


  217. MUKERJI CE, Lincoln SH, Tully LM, Dodell-Feder D, et al
    Neural simulation mechanisms and social-emotional function in schizophrenia.
    Psychiatry Res. 2017 Oct 24. pii: S0925-4927(17)30101.
    PubMed     Text format     Abstract available


  218. MARTINELLI C, Rigoli F, Dolan RJ, Shergill SS, et al
    Decreased value-sensitivity in schizophrenia.
    Psychiatry Res. 2017;259:295-301.
    PubMed     Text format     Abstract available


  219. HIRASAWA-FUJITAA M, Tudor L, Nikolac Pekovic M, Kozumplik O, et al
    Genotypic and haplotypic associations of catechol-O-methyltransferase (COMT) rs4680 and rs4818 with salivary cortisol in patients with schizophrenia.
    Psychiatry Res. 2017;259:262-264.
    PubMed     Text format    


  220. DAUVERMANN MR, Moorhead TW, Watson AR, Duff B, et al
    Verbal working memory and functional large-scale networks in schizophrenia.
    Psychiatry Res. 2017;270:86-96.
    PubMed     Text format     Abstract available


  221. SELLERS R, Wells A, Parker S, Morrison AP, et al
    Do people with psychosis engage in unhelpful metacognitive coping strategies? A test of the validity of the Cognitive Attentional Syndrome (CAS) in a clinical sample.
    Psychiatry Res. 2017;259:243-250.
    PubMed     Text format     Abstract available


  222. JAJODIA A, Kaur H, Srivastava A, Kumari K, et al
    Schizophrenia susceptibility and neuregulin signaling pathway genes: A rare haplotype combination based association study in Indian population.
    Psychiatry Res. 2017 Oct 10. pii: S0165-1781(17)30253.
    PubMed     Text format    


  223. LIUHANEN J, Suvisaari J, Kajantie E, Miettunen J, et al
    Interaction between compound genetic risk for schizophrenia and high birth weight contributes to social anhedonia and schizophrenia in women.
    Psychiatry Res. 2017;259:148-153.
    PubMed     Text format     Abstract available


  224. LEE H, Kim HK, Kwon JT, Park S, et al
    BBOX1 is down-regulated in maternal immune-activated mice and implicated in genetic susceptibility to human schizophrenia.
    Psychiatry Res. 2017;259:197-202.
    PubMed     Text format     Abstract available


  225. SUBRAMANIAM A, Danivas V, Mahavir Agarwal S, Kalmady S, et al
    Clinical correlates of saccadic eye movement in antipsychotic-naive schizophrenia.
    Psychiatry Res. 2017;259:154-159.
    PubMed     Text format     Abstract available


  226. CHEN GF, Liu LL, Cui JF, Chen T, et al
    Life review therapy enhances mental time travel in patients with schizophrenia.
    Psychiatry Res. 2017;258:145-152.
    PubMed     Text format     Abstract available


  227. RUIZ JC, Soler MJ, Dasi C, Fuentes I, et al
    The effect of associative strength on semantic priming in schizophrenia.
    Psychiatry Res. 2017;259:1-6.
    PubMed     Text format     Abstract available


  228. CAMPELLONE TR, Kring AM
    Anticipated pleasure for positive and negative social interaction outcomes in schizophrenia.
    Psychiatry Res. 2017;259:203-209.
    PubMed     Text format     Abstract available


  229. JEONG SH, Chung IW, Jung HY, Hwang SS, et al
    Comparison of clinician-rated and self-report insight in Korean patients with schizophrenia using VAGUS insight scale.
    Psychiatry Res. 2017;258:93-100.
    PubMed     Text format     Abstract available


    September 2017
  230. DANAHER H, Allott K, Killackey E, Hester R, et al
    An examination of sex differences in neurocognition and social cognition in first-episode psychosis.
    Psychiatry Res. 2017;259:36-43.
    PubMed     Text format     Abstract available


  231. CREMASCHI L, Kardell M, Johansson V, Isgren A, et al
    Prevalences of autoimmune diseases in schizophrenia, bipolar I and II disorder, and controls.
    Psychiatry Res. 2017;258:9-14.
    PubMed     Text format     Abstract available


  232. ERDENIZ B, Serin E, Ibadi Y, Tas C, et al
    Decreased functional connectivity in schizophrenia: The relationship between social functioning, social cognition and graph theoretical network measures.
    Psychiatry Res. 2017;270:22-31.
    PubMed     Text format     Abstract available


  233. BELAND S, Lepage M
    The relative contributions of social cognition and self-reflectiveness to clinical insight in enduring schizophrenia.
    Psychiatry Res. 2017;258:116-123.
    PubMed     Text format     Abstract available


  234. TSUI MCM, Tsang HWH
    Views of people with schizophrenia and their caregivers towards the needs for psychiatric rehabilitation in urban and rural areas of mainland China.
    Psychiatry Res. 2017;258:72-77.
    PubMed     Text format     Abstract available


  235. FUJIMAKI K, Toki S, Yamashita H, Oyamada T, et al
    Predictors of negative symptoms in the chronic phase of schizophrenia: A cross-sectional study.
    Psychiatry Res. 2017 Sep 24. pii: S0165-1781(17)30729.
    PubMed     Text format     Abstract available


  236. VITOLO E, Tatu MK, Pignolo C, Cauda F, et al
    White matter and schizophrenia: A meta-analysis of voxel-based morphometry and diffusion tensor imaging studies.
    Psychiatry Res. 2017;270:8-21.
    PubMed     Text format     Abstract available


  237. DOROFEIKOVA M, Neznanov N, Petrova N
    Cognitive deficit in patients with paranoid schizophrenia: Its clinical and laboratory correlates.
    Psychiatry Res. 2017 Sep 20. pii: S0165-1781(17)31459.
    PubMed     Text format     Abstract available


  238. CUESTA MJ, Lecumberri P, Cabada T, Moreno-Izco L, et al
    Basal ganglia and ventricle volume in first-episode psychosis. A family and clinical study.
    Psychiatry Res. 2017;269:90-96.
    PubMed     Text format     Abstract available


  239. MELBOURNE JK, Chase KA, Feiner B, Rosen C, et al
    Long non-coding and endogenous retroviral RNA levels are associated with proinflammatory cytokine mRNA expression in peripheral blood cells: Implications for schizophrenia.
    Psychiatry Res. 2017 Sep 14. pii: S0165-1781(16)32171.
    PubMed     Text format     Abstract available


  240. BRIGHT M, Parker S, French P, Fowler D, et al
    Metacognitive beliefs as psychological predictors of social functioning: An investigation with young people at risk of psychosis.
    Psychiatry Res. 2017 Sep 14. pii: S0165-1781(17)30197.
    PubMed     Text format     Abstract available


  241. CONTRERAS NA, Tan EJ, Lee SJ, Castle DJ, et al
    Using visual processing training to enhance standard cognitive remediation outcomes in schizophrenia: A pilot study.
    Psychiatry Res. 2017 Sep 14. pii: S0165-1781(16)30805.
    PubMed     Text format     Abstract available


  242. RATHEE R, Luhrmann TM, Bhatia T, Deshpande SN, et al
    Cognitive insight and objective quality of life in people with schizophrenia and auditory hallucinations.
    Psychiatry Res. 2017;259:223-228.
    PubMed     Text format     Abstract available


  243. FRESAN A, Robles-Garcia R, Madrigal E, Tovilla-Zarate CA, et al
    Demographic and clinical features related to perceived discrimination in schizophrenia.
    Psychiatry Res. 2017 Sep 9. pii: S0165-1781(17)30314.
    PubMed     Text format     Abstract available


  244. VANCAMPFORT D, Gorczynski P, De Hert M, Probst M, et al
    Exercise self-efficacy correlates in people with psychosis.
    Psychiatry Res. 2017 Sep 8. pii: S0165-1781(17)30413.
    PubMed     Text format     Abstract available


  245. CATHERINE FA, Aurelie V, Eric G, Pierre M, et al
    Defining functioning levels in patients with schizophrenia: A combination of a novel clustering method and brain SPECT analysis.
    Psychiatry Res. 2017;270:32-38.
    PubMed     Text format     Abstract available


  246. KILICASLAN EE, Esen AT, Kasal MI, Ozelci E, et al
    Childhood trauma, depression, and sleep quality and their association with psychotic symptoms and suicidality in schizophrenia.
    Psychiatry Res. 2017 Sep 7. pii: S0165-1781(17)30902.
    PubMed     Text format     Abstract available


  247. MORENO-SAMANIEGO L, Gaviria AM, Vilella E, Valero J, et al
    Schizotypal traits and cognitive performance in siblings of patients with psychosis.
    Psychiatry Res. 2017 Sep 7. pii: S0165-1781(17)30539.
    PubMed     Text format     Abstract available


  248. WATSON AJ, Joyce EM, Fugard AJB, Leeson VC, et al
    More haste less speed: A meta-analysis of thinking latencies during planning in people with psychosis.
    Psychiatry Res. 2017 Sep 5. pii: S0165-1781(17)30175.
    PubMed     Text format     Abstract available


    August 2017
  249. LINDGREN M, Mantyla T, Rikandi E, Torniainen-Holm M, et al
    Childhood adversities and clinical symptomatology in first-episode psychosis.
    Psychiatry Res. 2017 Aug 26. pii: S0165-1781(17)30756.
    PubMed     Text format     Abstract available


  250. NIIMURA J, Nakanishi M, Yamasaki S, Nishida A, et al
    Regional supply of outreach service and length of stay in psychiatric hospital among patients with schizophrenia: National case mix data analysis in Japan.
    Psychiatry Res. 2017 Aug 24. pii: S0165-1781(16)32185.
    PubMed     Text format     Abstract available


  251. REMPFER MV, McDowd JM, Brown CE
    Measuring learning potential in people with schizophrenia: A comparison of two tasks.
    Psychiatry Res. 2017 Aug 24. pii: S0165-1781(17)30544.
    PubMed     Text format     Abstract available


  252. BO Q, Li F, Li X, Wang Z, et al
    Symptomatic remission in schizophrenia: Results from a risperidone maintenance treatment study.
    Psychiatry Res. 2017 Aug 24. pii: S0165-1781(16)31337.
    PubMed     Text format     Abstract available


  253. WU C, Dagg P, Molgat C
    Measuring stability of cognitive impairment in inpatients with schizophrenia with alternate forms of the Montreal Cognitive Assessment during acute hospitalization.
    Psychiatry Res. 2017 Aug 24. pii: S0165-1781(17)30592.
    PubMed     Text format     Abstract available


  254. SU CT, Yang AL, Lin CY
    Comparing two schizophrenia-specific quality of life instruments in institutionalized people with schizophrenia.
    Psychiatry Res. 2017 Aug 23. pii: S0165-1781(17)30674.
    PubMed     Text format     Abstract available


  255. AGAY N, Flaks-Manov N, Nitzan U, Hoshen MB, et al
    Cancer prevalence in men and women with schizophrenia.
    Psychiatry Res. 2017 Aug 19. pii: S0165-1781(17)30123.
    PubMed     Text format     Abstract available


  256. POS K, de Wit IE, van Dijk FA, Bartels-Velthuis AA, et al
    An experience sampling study on the ecological validity of the SWN-20: Indication that subjective well-being is associated with momentary affective states above and beyond psychosis susceptibility.
    Psychiatry Res. 2017 Aug 18. pii: S0165-1781(16)31386.
    PubMed     Text format     Abstract available


  257. CHIU YL, Lin HC, Kao NW, Kao S, et al
    Increased risk of concurrent hepatitis C among Male patients with schizophrenia.
    Psychiatry Res. 2017 Aug 18. pii: S0165-1781(16)31998.
    PubMed     Text format     Abstract available


  258. CHEN KW, Lee SC, Chiang HY, Syu YC, et al
    Psychometric properties of three measures assessing advanced theory of mind: Evidence from people with schizophrenia.
    Psychiatry Res. 2017;257:490-496.
    PubMed     Text format     Abstract available


  259. JIANG T, Zong L, Zhou L, Hou Y, et al
    Variation in global DNA hydroxymethylation with age associated with schizophrenia.
    Psychiatry Res. 2017;257:497-500.
    PubMed     Text format     Abstract available


  260. ANDERSON AE, Mansolf M, Reise SP, Savitz A, et al
    Measuring pathology using the PANSS across diagnoses: Inconsistency of the positive symptom domain across schizophrenia, schizoaffective, and bipolar disorder.
    Psychiatry Res. 2017 Aug 16. pii: S0165-1781(16)31411.
    PubMed     Text format     Abstract available


  261. WESTERMANN S, Grezellschak S, Oravecz Z, Moritz S, et al
    Untangling the complex relationships between symptoms of schizophrenia and emotion dynamics in daily life: Findings from an experience sampling pilot study.
    Psychiatry Res. 2017;257:514-518.
    PubMed     Text format     Abstract available


  262. HUANG H, Shu C, Chen J, Zou J, et al
    Altered corticostriatal pathway in first-episode paranoid schizophrenia: Resting-state functional and causal connectivity analyses.
    Psychiatry Res. 2017 Aug 15. pii: S0925-4927(17)30093.
    PubMed     Text format     Abstract available


  263. HSWEN Y, Naslund JA, Chandrashekar P, Siegel R, et al
    Exploring online communication about cigarette smoking among Twitter users who self-identify as having schizophrenia.
    Psychiatry Res. 2017;257:479-484.
    PubMed     Text format     Abstract available


  264. VADHAN NP, Corcoran CM, Bedi G, Keilp JG, et al
    Acute effects of smoked marijuana in marijuana smokers at clinical high-risk for psychosis: A preliminary study.
    Psychiatry Res. 2017;257:372-374.
    PubMed     Text format     Abstract available


  265. LYSAKER PH, George S, Chaudoin-Patzoldt KA, Pec O, et al
    Contrasting metacognitive, social cognitive and alexithymia profiles in adults with borderline personality disorder, schizophrenia and substance use disorder.
    Psychiatry Res. 2017;257:393-399.
    PubMed     Text format     Abstract available


  266. FAVROD O, Sierro G, Roinishvili M, Chkonia E, et al
    Electrophysiological correlates of visual backward masking in high schizotypic personality traits participants.
    Psychiatry Res. 2017;254:251-257.
    PubMed     Text format     Abstract available


  267. WANG YY, Shi HS, Liu WH, Yan C, et al
    Invariance of factor structure of the 21-item Peters et al. Delusions Inventory (PDI-21) over time and across samples.
    Psychiatry Res. 2017;254:190-197.
    PubMed     Text format     Abstract available


    July 2017
  268. TESSIER A, Boyer L, Husky M, Bayle F, et al
    Medication adherence in schizophrenia: The role of insight, therapeutic alliance and perceived trauma associated with psychiatric care.
    Psychiatry Res. 2017;257:315-321.
    PubMed     Text format     Abstract available


  269. ABRAHAMSE E, Ruitenberg M, Boddewyn S, Oreel E, et al
    Conflict adaptation in patients diagnosed with schizophrenia.
    Psychiatry Res. 2017;257:260-264.
    PubMed     Text format     Abstract available


  270. WILKINS LK, Girard TA, Herdman KA, Christensen BK, et al
    Hippocampal activation and memory in schizophrenia depend on spatial strategy use in a virtual maze.
    Psychiatry Res. 2017;268:1-8.
    PubMed     Text format     Abstract available


  271. TULLY S, Wells A, Morrison AP
    Attentional avoidance increases voice hearing in an analogue task in people with psychosis: An experimental study.
    Psychiatry Res. 2017;257:186-192.
    PubMed     Text format     Abstract available


  272. VERAS AB, Cougo S, Meira F, Peixoto C, et al
    Schizophrenia dissection by five anxiety and depressive subtype comorbidities: Clinical implications and evolutionary perspective.
    Psychiatry Res. 2017;257:172-178.
    PubMed     Text format     Abstract available


  273. SMIRNOVA D, Clark M, Jablensky A, Badcock JC, et al
    Action (verb) fluency deficits in schizophrenia spectrum disorders: linking language, cognition and interpersonal functioning.
    Psychiatry Res. 2017;257:203-211.
    PubMed     Text format     Abstract available


  274. DEMRO C, Rowland L, Wijtenburg SA, Waltz J, et al
    Glutamatergic metabolites among adolescents at risk for psychosis.
    Psychiatry Res. 2017;257:179-185.
    PubMed     Text format     Abstract available


  275. LI H, Shen Y, Wang G, Shi J, et al
    A 6-week, multicenter, double-blind, double-dummy, chlorpromazine-controlled non-inferiorityrandomized phase iiitrial to evaluate the efficacy and safety of quetiapine fumarate (SEROQUEL) extended-release (XR) in the treatment of patients with schizop
    Psychiatry Res. 2017;259:117-124.
    PubMed     Text format     Abstract available


  276. SU YA, Yan F, Li Q, Xiang YT, et al
    Anticholinergic use trends in 14,013 patients with schizophrenia from three national surveys on the use of psychotropic medications in China (2002-2012).
    Psychiatry Res. 2017;257:132-136.
    PubMed     Text format     Abstract available


  277. HILL K, Bolo N, Sarvode Mothi S, Lizano P, et al
    Subcortical surface shape in youth at familial high risk for schizophrenia.
    Psychiatry Res. 2017;267:36-44.
    PubMed     Text format     Abstract available


  278. POPOLO R, Smith E, Lysaker PH, Lestingi K, et al
    Metacognitive profiles in schizophrenia and bipolar disorder: Comparisons with healthy controls and correlations with negative symptoms.
    Psychiatry Res. 2017;257:45-50.
    PubMed     Text format     Abstract available


  279. MANOUILENKO I, Humble MB, Georgieva J, Bejerot S, et al
    Brainstem Auditory Evoked Potentials for diagnosing Autism Spectrum Disorder, ADHD and Schizophrenia Spectrum Disorders in adults. A blinded study.
    Psychiatry Res. 2017;257:21-26.
    PubMed     Text format     Abstract available


  280. SKIBINSKA M, Kapelski P, Pawlak J, Rajewska-Rager A, et al
    Glial Cell Line-Derived Neurotrophic Factor (GDNF) serum level in women with schizophrenia and depression, correlation with clinical and metabolic parameters.
    Psychiatry Res. 2017;256:396-402.
    PubMed     Text format     Abstract available


  281. TRIXLER D, Tenyi T
    Iris structure and minor physical anomalies in schizophrenia.
    Psychiatry Res. 2017;256:412-416.
    PubMed     Text format     Abstract available


  282. PETRIKIS P, Voulgari PV, Tzallas AT, Boumba VA, et al
    Changes in the cytokine profile in first-episode, drug-naive patients with psychosis after short-term antipsychotic treatment.
    Psychiatry Res. 2017;256:378-383.
    PubMed     Text format     Abstract available


  283. KULKARNI K, Arasappa R, Prasad M K, Zutshi A, et al
    Risperidone versus olanzapine in the acute treatment of Persistent Delusional Disorder: A retrospective analysis.
    Psychiatry Res. 2017;253:270-273.
    PubMed     Text format     Abstract available


    June 2017
  284. ROSSI A, Galderisi S, Rocca P, Bertolino A, et al
    Personal resources and depression in schizophrenia: The role of self-esteem, resilience and internalized stigma.
    Psychiatry Res. 2017;256:359-364.
    PubMed     Text format     Abstract available


  285. WEISMAN DE MAMANI A, Weintraub MJ, Maura J, Martinez de Andino A, et al
    Acculturation styles and their associations with psychiatric symptoms and quality of life in ethnic minorities with schizophrenia.
    Psychiatry Res. 2017;255:418-423.
    PubMed     Text format     Abstract available


  286. HARROW M, Jobe TH, Faull RN, Yang J, et al
    A 20-Year multi-followup longitudinal study assessing whether antipsychotic medications contribute to work functioning in schizophrenia.
    Psychiatry Res. 2017;256:267-274.
    PubMed     Text format     Abstract available


  287. WANG Y, Wang Y, Zhao Q, Cui JF, et al
    Preliminary study of visual perspective in mental time travel in schizophrenia.
    Psychiatry Res. 2017;256:225-227.
    PubMed     Text format     Abstract available


  288. LEE HS, Jang SK, Lee GY, Park SC, et al
    Informationally administered reward enhances intrinsic motivation in schizophrenia.
    Psychiatry Res. 2017;256:290-297.
    PubMed     Text format     Abstract available


  289. KISHI T, Inada K, Matsui Y, Iwata N, et al
    Z-drug for schizophrenia: A systematic review and meta-analysis.
    Psychiatry Res. 2017;256:365-370.
    PubMed     Text format     Abstract available


  290. LANGDON R, Connors M, Connaughton E
    Indirect task instructions better reveal theory-of-mind impairment, independent of executive dysfunction, in schizophrenia.
    Psychiatry Res. 2017;256:342-344.
    PubMed     Text format     Abstract available


  291. CASTRO-DE-ARAUJO LFS, Kanaan RAA
    First episode psychosis moderates the effect of gray matter volume on cognition.
    Psychiatry Res. 2017;266:108-113.
    PubMed     Text format     Abstract available


  292. SHE S, Zhang B, Li X, Zhang X, et al
    Face-related visual search deficits in first-episode schizophrenia.
    Psychiatry Res. 2017;256:144-149.
    PubMed     Text format     Abstract available


  293. HANLON MC, Campbell LE, Single N, Coleman C, et al
    Men and women with psychosis and the impact of illness-duration on sex-differences: The second Australian national survey of psychosis.
    Psychiatry Res. 2017;256:130-143.
    PubMed     Text format     Abstract available


  294. MANSUETO G, Faravelli C
    Recent life events and psychosis: The role of childhood adversities.
    Psychiatry Res. 2017;256:111-117.
    PubMed     Text format     Abstract available


  295. PERRY BI, Salimkumar D, Green D, Meakin A, et al
    Associated illness severity in schizophrenia and diabetes mellitus: A systematic review.
    Psychiatry Res. 2017;256:102-110.
    PubMed     Text format     Abstract available


  296. OKUBO R, Inoue T, Hashimoto N, Suzukawa A, et al
    The mediator effect of personality traits on the relationship between childhood abuse and depressive symptoms in schizophrenia.
    Psychiatry Res. 2017;257:126-131.
    PubMed     Text format     Abstract available


  297. HUANG ACW, Bo-Han He A, Chen CC
    An examination of the roles of glutamate and sex in latent inhibition: Relevance to the glutamate hypothesis of schizophrenia?
    Psychiatry Res. 2017;256:46-52.
    PubMed     Text format     Abstract available


  298. HOFER A, Radner V, Edlinger M, Kemmler G, et al
    Why do indiviuals with schizophrenia drop out of observational clinical trials?
    Psychiatry Res. 2017;256:1-5.
    PubMed     Text format     Abstract available


  299. CALDANI S, Amado I, Bendjemaa N, Vialatte F, et al
    Oculomotricity and Neurological Soft Signs: Can we refine the endophenotype? A study in subjects belonging to the spectrum of schizophrenia.
    Psychiatry Res. 2017;256:490-497.
    PubMed     Text format     Abstract available


  300. RAPP C, Canela C, Studerus E, Walter A, et al
    Duration of untreated psychosis/illness and brain volume changes in early psychosis.
    Psychiatry Res. 2017;255:332-337.
    PubMed     Text format     Abstract available


  301. KARPOUZIAN TM, Schroeder MP, Abram SV, Wanar H, et al
    Neural correlates of preserved facial affect perception in high functioning schizophrenia.
    Psychiatry Res. 2017;266:83-85.
    PubMed     Text format     Abstract available


  302. SURMANN M, Gruchalla LV, Falke S, Maisch B, et al
    The importance of strengthening competence and control beliefs in patients with psychosis to reduce treatment hindering self-stigmatization.
    Psychiatry Res. 2017;255:314-320.
    PubMed     Text format     Abstract available


    May 2017
  303. CANAL-RIVERO M, Lopez-Morinigo JD, Barrigon ML, Perona-Garcelan S, et al
    The role of premorbid personality and social cognition in suicidal behaviour in first-episode psychosis: A one-year follow-up study.
    Psychiatry Res. 2017;256:13-20.
    PubMed     Text format     Abstract available


  304. GABRIEL D, Jakubovski E, Taylor JH, Artukoglu BB, et al
    Predictors of treatment response and drop out in the Treatment of Early-Onset Schizophrenia Spectrum Disorders (TEOSS) study.
    Psychiatry Res. 2017;255:248-255.
    PubMed     Text format     Abstract available


  305. BJORNESTAD J, Hegelstad WTV, Joa I, Davidson L, et al
    "With a little help from my friends" social predictors of clinical recovery in first-episode psychosis.
    Psychiatry Res. 2017;255:209-214.
    PubMed     Text format     Abstract available


  306. LI J, Guo YB, Huang YG, Liu JW, et al
    Stigma and discrimination experienced by people with schizophrenia living in the community in Guangzhou, China.
    Psychiatry Res. 2017;255:225-231.
    PubMed     Text format     Abstract available


  307. TIMUCIN OB, Mutlu EA, Timucin D, Aslanci ME, et al
    Psychophysical assessment of koniocellular pathway in patients with schizophrenia versus healthy controls.
    Psychiatry Res. 2017;266:27-34.
    PubMed     Text format     Abstract available


  308. NENADIC I, Hoof A, Dietzek M, Langbein K, et al
    Diffusion tensor imaging of cingulum bundle and corpus callosum in schizophrenia vs. bipolar disorder.
    Psychiatry Res. 2017;266:96-100.
    PubMed     Text format     Abstract available


  309. NENADIC I, Dietzek M, Langbein K, Sauer H, et al
    BrainAGE score indicates accelerated brain aging in schizophrenia, but not bipolar disorder.
    Psychiatry Res. 2017;266:86-89.
    PubMed     Text format     Abstract available


  310. PRISTED SG, Correll CU, Nielsen J
    Frequency and correlates of anticholinergic use among patients with schizophrenia in Denmark: A Nation-wide pharmacoepidemiological study.
    Psychiatry Res. 2017;255:198-203.
    PubMed     Text format     Abstract available


  311. TAKAHASHI T, Takayanagi Y, Nishikawa Y, Nakamura M, et al
    Brain neurodevelopmental markers related to the deficit subtype of schizophrenia.
    Psychiatry Res. 2017;266:10-18.
    PubMed     Text format     Abstract available


  312. HUHTANISKA S, Jaaskelainen E, Heikka T, Moilanen JS, et al
    Long-term antipsychotic and benzodiazepine use and brain volume changes in schizophrenia: The Northern Finland Birth Cohort 1966 study.
    Psychiatry Res. 2017;266:73-82.
    PubMed     Text format     Abstract available


  313. CARNEY R, Cotter J, Bradshaw T, Yung AR, et al
    Examining the physical health and lifestyle of young people at ultra-high risk for psychosis: A qualitative study involving service users, parents and clinicians.
    Psychiatry Res. 2017;255:87-93.
    PubMed     Text format     Abstract available


  314. FLAHERTY LR, Daniels K, Luther J, Haas GL, et al
    Reduction of medical hospitalizations in veterans with schizophrenia using home telehealth.
    Psychiatry Res. 2017;255:153-155.
    PubMed     Text format     Abstract available


  315. SCHOELER T, Petros N, Di Forti M, Klamerus E, et al
    Effect of continued cannabis use on medication adherence in the first two years following onset of psychosis.
    Psychiatry Res. 2017;255:36-41.
    PubMed     Text format     Abstract available


  316. WOOD L, Byrne R, Burke E, Enache G, et al
    The impact of stigma on emotional distress and recovery from psychosis: The mediatory role of internalised shame and self-esteem.
    Psychiatry Res. 2017;255:94-100.
    PubMed     Text format     Abstract available


  317. BOUAZIZ N, Moulier V, Lettelier-Galle T, Osmond I, et al
    Impact of reward on pain threshold and tolerance to experimental pain (Cold Pressor Task) in healthy subjects and patients with schizophrenia.
    Psychiatry Res. 2017;254:275-278.
    PubMed     Text format    


  318. BIAGIARELLI M, Curto M, Di Pomponio I, Comparelli A, et al
    Antipsychotic treatment and the Rorschach Perceptual Thinking Index (PTI) in psychotic disorder patients: Effects of treatment.
    Psychiatry Res. 2017;251:294-297.
    PubMed     Text format     Abstract available


    April 2017
  319. TERACHI S, Yamada T, Pu S, Yokoyama K, et al
    Comparison of neurocognitive function in major depressive disorder, bipolar disorder, and schizophrenia in later life: A cross-sectional study of euthymic or remitted, non-demented patients using the Japanese version of the Brief Assessment of Cogniti
    Psychiatry Res. 2017;254:205-210.
    PubMed     Text format     Abstract available


  320. GARRIDO G, Penades R, Barrios M, Aragay N, et al
    Computer-assisted cognitive remediation therapy in schizophrenia: Durability of the effects and cost-utility analysis.
    Psychiatry Res. 2017;254:198-204.
    PubMed     Text format     Abstract available


  321. ISHIWATA S, Hattori K, Sasayama D, Teraishi T, et al
    Plasma and cerebrospinal fluid G72 protein levels in schizophrenia and major depressive disorder.
    Psychiatry Res. 2017;254:244-250.
    PubMed     Text format     Abstract available


  322. SHE S, Deng Y, Chen Y, Wu C, et al
    Two-stage integrated care versus antipsychotic medication alone on outcomes of schizophrenia: One-year randomized controlled trial and follow-up.
    Psychiatry Res. 2017;254:164-172.
    PubMed     Text format     Abstract available


  323. DEMPSTER K, Norman R, Theberge J, Densmore M, et al
    Cognitive performance is associated with gray matter decline in first-episode psychosis.
    Psychiatry Res. 2017;264:46-51.
    PubMed     Text format     Abstract available


  324. GUO W, Liu F, Chen J, Wu R, et al
    Using short-range and long-range functional connectivity to identify schizophrenia with a family-based case-control design.
    Psychiatry Res. 2017;264:60-67.
    PubMed     Text format     Abstract available


  325. ERTEKIN E, Ucok A, Keskin-Ergen Y, Devrim-Ucok M, et al
    Deficits in Go and NoGo P3 potentials in patients with schizophrenia.
    Psychiatry Res. 2017;254:126-132.
    PubMed     Text format     Abstract available


  326. SIMONSEN C, Faerden A, Romm KL, Berg AO, et al
    Early clinical recovery in first-episode psychosis: Symptomatic remission and its correlates at 1-year follow-up.
    Psychiatry Res. 2017;254:118-125.
    PubMed     Text format     Abstract available


  327. LI Y, Hou CL, Ma XR, Zhong BL, et al
    Quality of life in Chinese patients with schizophrenia treated in primary care.
    Psychiatry Res. 2017;254:80-84.
    PubMed     Text format     Abstract available


  328. GALLETTI C, Paolini E, Tortorella A, Compton MT, et al
    Auditory and non-auditory hallucinations in first-episode psychosis: Differential associations with diverse clinical features.
    Psychiatry Res. 2017;254:268-274.
    PubMed     Text format     Abstract available


  329. TSOTSI S, Kosmidis MH, Bozikas VP
    Improved facial affect recognition in schizophrenia following an emotion intervention, but not training attention-to-facial-features or treatment-as-usual.
    Psychiatry Res. 2017;254:135-142.
    PubMed     Text format     Abstract available


  330. DA SILVA S, Saperia S, Siddiqui I, Fervaha G, et al
    Investigating consummatory and anticipatory pleasure across motivation deficits in schizophrenia and healthy controls.
    Psychiatry Res. 2017;254:112-117.
    PubMed     Text format     Abstract available


  331. OHMURO N, Matsumoto K, Ishii Y, Katsura M, et al
    The associations between quality of life and clinical symptoms in individuals with an at-risk mental state and first-episode psychosis.
    Psychiatry Res. 2017;254:54-59.
    PubMed     Text format     Abstract available


  332. ARMANDO M, Lin A, Pontillo M, Vicari S, et al
    Prevalence and treatment of psychiatric disorders other than psychosis in children and adolescents with 22q11DS: Examining associations with social and role functioning.
    Psychiatry Res. 2017;254:238-243.
    PubMed     Text format     Abstract available


  333. FOND G, Godin O, Boyer L, Llorca PM, et al
    Advanced paternal age is associated with earlier schizophrenia onset in offspring. Results from the national multicentric FACE-SZ cohort.
    Psychiatry Res. 2017;254:218-223.
    PubMed     Text format     Abstract available


  334. ORLIAC F, Delamillieure P, Delcroix N, Naveau M, et al
    Network modeling of resting state connectivity points towards the bottom up theories of schizophrenia.
    Psychiatry Res. 2017;266:19-26.
    PubMed     Text format     Abstract available


  335. BELGE JB, Maurage P, Mangelinckx C, Leleux D, et al
    Facial decoding in schizophrenia is underpinned by basic visual processing impairments.
    Psychiatry Res. 2017;255:167-172.
    PubMed     Text format     Abstract available


  336. LO CASCIO N, Curto M, Pasqualetti P, Lindau JF, et al
    Impairment in Social Functioning differentiates youth meeting Ultra-High Risk for psychosis criteria from other mental health help-seekers: A validation of the Italian version of the Global Functioning: Social and Global Functioning: Role scales.
    Psychiatry Res. 2017;253:296-302.
    PubMed     Text format     Abstract available


  337. COENTRE R, Talina MC, Gois C, Figueira ML, et al
    Depressive symptoms and suicidal behavior after first-episode psychosis: A comprehensive systematic review.
    Psychiatry Res. 2017;253:240-248.
    PubMed     Text format     Abstract available


  338. RAVICHANDRAN C, Shinn AK, Ongur D, Perlis RH, et al
    Frequency of non-right-handedness in bipolar disorder and schizophrenia.
    Psychiatry Res. 2017;253:267-269.
    PubMed     Text format     Abstract available


  339. BAHORIK AL, Greeno CG, Cochran G, Cornelius JR, et al
    Motivation deficits and use of alcohol and illicit drugs among individuals with schizophrenia.
    Psychiatry Res. 2017;253:391-397.
    PubMed     Text format     Abstract available


  340. BORTOLON C, Capdevielle D, Altman R, Macgregor A, et al
    Mirror self-face perception in individuals with schizophrenia: Feelings of strangeness associated with one's own image.
    Psychiatry Res. 2017;253:205-210.
    PubMed     Text format     Abstract available


  341. HUMPSTON CS, Linden DEJ, Evans LH
    Deficits in reality and internal source monitoring of actions are associated with the positive dimension of schizotypy.
    Psychiatry Res. 2017;250:44-49.
    PubMed     Text format     Abstract available


    March 2017
  342. KALMADY SV, Shivakumar V, Arasappa R, Subramaniam A, et al
    Clinical correlates of hippocampus volume and shape in antipsychotic-naive schizophrenia.
    Psychiatry Res. 2017;263:93-102.
    PubMed     Text format     Abstract available


  343. WU XJ, Zeng LL, Shen H, Yuan L, et al
    Functional network connectivity alterations in schizophrenia and depression.
    Psychiatry Res. 2017;263:113-120.
    PubMed     Text format     Abstract available


  344. WANG C, Zhang Y
    Season of birth and schizophrenia: Evidence from China.
    Psychiatry Res. 2017;253:189-196.
    PubMed     Text format     Abstract available


  345. WUSTEN C, Lincoln TM
    The association of family functioning and psychosis proneness in five countries that differ in cultural values and family structures.
    Psychiatry Res. 2017;253:158-164.
    PubMed     Text format     Abstract available


  346. BOLL KM, Noto C, Bonifacio KL, Bortolasci CC, et al
    Oxidative and nitrosative stress biomarkers in chronic schizophrenia.
    Psychiatry Res. 2017;253:43-48.
    PubMed     Text format     Abstract available


  347. JAHSHAN C, Wolf M, Karbi Y, Shamir E, et al
    Probing the magnocellular and parvocellular visual pathways in facial emotion perception in schizophrenia.
    Psychiatry Res. 2017;253:38-42.
    PubMed     Text format     Abstract available


  348. FORNS-NADAL M, Berge D, Sem F, Mane A, et al
    Increased nucleus accumbens volume in first-episode psychosis.
    Psychiatry Res. 2017;263:57-60.
    PubMed     Text format     Abstract available


  349. RAFFARD S, Bortolon C, Stephan Y, Capdevielle D, et al
    Personality traits are associated with the valence of future imagined events in individuals with schizophrenia.
    Psychiatry Res. 2017;253:138-141.
    PubMed     Text format     Abstract available


  350. VANCAMPFORT D, De Hert M, Myin-Germeys I, van Winkel R, et al
    Lower cardiorespiratory fitness is associated with more time spent sedentary in first episode psychosis: A pilot study.
    Psychiatry Res. 2017;253:13-17.
    PubMed     Text format     Abstract available


  351. LUAN Z, Zhang D
    The anaplastic lymphoma kinase (ALK) gene is associated with schizophrenia in a Chinese population.
    Psychiatry Res. 2017 Mar 9. pii: S0165-1781(16)31996.
    PubMed     Text format    


  352. GROVER S, Sahoo S, Dua D, Chakrabarti S, et al
    Scales for assessment of depression in schizophrenia: Factor analysis of calgary depression rating scale and hamilton depression rating scale.
    Psychiatry Res. 2017;252:333-339.
    PubMed     Text format     Abstract available


  353. LARIVIERE S, Lavigne KM, Woodward TS, Gerretsen P, et al
    Altered functional connectivity in brain networks underlying self-referential processing in delusions of reference in schizophrenia.
    Psychiatry Res. 2017;263:32-43.
    PubMed     Text format     Abstract available


  354. MI W, Zhang S, Liu Q, Yang F, et al
    Prevalence and risk factors of agitation in newly hospitalized schizophrenia patients in China: An observational survey.
    Psychiatry Res. 2017;253:401-406.
    PubMed     Text format     Abstract available


    February 2017
  355. BI Y, Huang X, Niu W, Chen S, et al
    No association between SLC6A2, SLC6A3, DRD2 polymorphisms and schizophrenia in the Han Chinese population.
    Psychiatry Res. 2017;253:398-400.
    PubMed     Text format     Abstract available


  356. JAMES BO, Omoaregba JO, Raji SO, Imishue OE, et al
    Attitudes towards and rationale for antipsychotic polypharmacy among psychiatrists in Nigeria: Characteristics associated with high reported antipsychotic polypharmacy.
    Psychiatry Res. 2017;248:134-139.
    PubMed     Text format     Abstract available


    January 2017
  357. KEGEL ME, Johansson V, Wetterberg L, Bhat M, et al
    Kynurenic acid and psychotic symptoms and personality traits in twins with psychiatric morbidity.
    Psychiatry Res. 2017;247:105-112.
    PubMed     Text format     Abstract available


  358. ENGEL M, Lincoln TM
    Concordance of self- and observer-rated motivation and pleasure in patients with negative symptoms and healthy controls.
    Psychiatry Res. 2017;247:1-5.
    PubMed     Text format     Abstract available


  359. FAGIOLINI A, Rocca P, De Giorgi S, Spina E, et al
    Clinical trial methodology to assess the efficacy/effectiveness of long-acting antipsychotics: Randomized controlled trials vs naturalistic studies.
    Psychiatry Res. 2017;247:257-264.
    PubMed     Text format     Abstract available


Thank you for your interest in scientific medicine.


AMEDEO Schizophrenia is free of charge.
This policy is made possible thanks to a media sponsorship by Boehringer Ingelheim.

Design: